https://www.clarivate.com.cn/life-sciences-healthcare/blog/ 2025-12-08T08:46:40+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/blog/navigating-early-decisions-that-shape-drug-development/ 2026-07-02T10:38:36+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/blog/five-lessons-learned-deploying-agentic-ai-in-the-life-sciences/ 2026-06-29T12:32:13+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/blog/the-market-access-sweet-spots-where-payers-reimburse-more-convenient-therapies/ 2026-06-29T12:29:07+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/blog/why-longevity-might-be-biopharmas-next-big-thing/ 2026-06-29T12:26:33+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/blog/the-competitive-signals-hiding-in-plain-sight-for-biopharma/ 2026-06-24T12:16:14+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/blog/drugs-to-watch-2026-qa-lillys-next-generation-weight-loss-drugs/ 2026-06-17T07:06:30+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/blog/relacorilant-crl-fda-evidence-bar/ 2026-06-15T04:05:59+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/blog/5-medtech-trends-to-watch-in-2026/ 2026-05-28T11:35:36+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/blog/tolebrutinib-crl-safety-overrides-efficacy/ 2026-04-30T10:19:47+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/blog/navigating-fda-complete-response-letters-clarivate/ 2026-04-30T10:12:40+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/blog/why-ease-of-administration-in-new-drugs-sometimes-draws-a-yawn-from-payers/ 2026-04-16T06:56:19+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/blog/six-companies-enabling-precision-interventions-for-undruggable-targets/ 2026-04-16T06:56:11+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/blog/key-market-access-considerations-for-long-acting-and-alternative-delivery-therapies/ 2026-04-01T10:27:22+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/blog/seven-companies-forging-new-paths-in-womens-health/ 2026-03-30T09:46:27+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/blog/what-comes-after-fda-complete-response-letter/ 2026-03-30T09:40:14+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/blog/how-creative-design-can-elevate-your-healthcare-value-communication-tools/ 2026-03-27T10:12:23+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/wp-content/uploads/sites/4/2026/01/Your-healthcare-value-communication-tools_Blog-CN-1.jpg https://www.clarivate.com.cn/life-sciences-healthcare/blog/forecasting-target-markets-using-epidemiology-data/ 2026-03-27T10:10:12+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/wp-content/uploads/sites/4/2026/01/2ed2235e62b41e0e98e24cfcbe8648a4.jpg https://www.clarivate.com.cn/life-sciences-healthcare/wp-content/uploads/sites/4/2026/01/b4ff06ab851bcd477c06a72793f355a7-scaled.jpg https://www.clarivate.com.cn/life-sciences-healthcare/blog/new-enrollment-data-shows-health-insurance-disruption/ 2026-03-27T08:51:55+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/blog/ai-and-clinical-diagnostics-following-the-road-less-travelled/ 2026-03-27T08:42:49+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/wp-content/uploads/sites/4/2025/01/ai_and_clinical_diagnostic_picture1.png https://www.clarivate.com.cn/life-sciences-healthcare/wp-content/uploads/sites/4/2025/01/ai_and_clinical_diagnostic_picture2.png https://www.clarivate.com.cn/life-sciences-healthcare/wp-content/uploads/sites/4/2025/01/ai_and_clinical_diagnostics_picture3.png https://www.clarivate.com.cn/life-sciences-healthcare/blog/5-key-time-saving-benefits-of-ai-driven-regulatory-intelligence/ 2026-03-27T08:37:18+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/blog/machine-curation-in-action-a-new-approach-to-essential-tremor-epidemiology/ 2026-03-27T08:28:12+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/blog/streamlining-regulatory-compliance-with-ai-enabled-intelligence/ 2026-03-12T08:59:34+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/blog/glp-1-weight-loss-access-comes-down-to-a-dogfight-in-the-u-s/ 2026-03-12T08:50:10+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/blog/antibody-drug-conjugates-and-bispecifics-seize-the-spotlight-at-asco-2022/ 2026-03-12T08:47:50+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/blog/understanding-a-rare-disease-through-the-lens-of-real-world-and-prevalence-data/ 2026-03-12T08:46:18+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/wp-content/uploads/sites/4/2023/07/Picture1.png https://www.clarivate.com.cn/life-sciences-healthcare/wp-content/uploads/sites/4/2023/07/Picture2.png https://www.clarivate.com.cn/life-sciences-healthcare/wp-content/uploads/sites/4/2023/07/Picture3.png https://www.clarivate.com.cn/life-sciences-healthcare/blog/u-s-market-access-landscape-a-push-for-control-is-erasing-the-boundary-between-payers-and-providers-in-u-s-healthcare/ 2026-03-12T08:45:29+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/blog/mainland-chinas-regulatory-evolution-brings-greater-access-to-novel-drugs/ 2026-03-12T08:43:50+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/wp-content/uploads/sites/4/2023/07/Picture2-1.png https://www.clarivate.com.cn/life-sciences-healthcare/wp-content/uploads/sites/4/2023/07/Picture1-1.png https://www.clarivate.com.cn/life-sciences-healthcare/blog/real-world-data-reveal-how-diseases-manifest-in-diverse-populations/ 2026-03-12T08:42:32+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/blog/what-a-string-of-semaglutide-biosimilars-could-mean-for-mainland-china/ 2026-03-12T08:40:06+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/wp-content/uploads/sites/4/2025/01/string_of_semaglutide_picture1.png https://www.clarivate.com.cn/life-sciences-healthcare/blog/indication-expansion-pioneering-new-uses-for-existing-cancer-drugs/ 2026-03-12T08:35:27+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/wp-content/uploads/sites/4/2025/01/indication_expansion_picture1.jpg https://www.clarivate.com.cn/life-sciences-healthcare/wp-content/uploads/sites/4/2025/01/indication_expansion_picture2.png https://www.clarivate.com.cn/life-sciences-healthcare/blog/these-seven-adc-makers-are-developing-therapies-that-show-promise-for-hard-to-treat-cancers/ 2026-03-12T08:33:05+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/blog/perceptions-of-pharmaceutical-industry-affiliates-on-the-new-active-substance-work-sharing-initiative-of-the-access-consortium/ 2026-03-12T08:28:13+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/wp-content/uploads/sites/4/2025/01/perceptions_of_pharmaceutical_industry_picture7.png https://www.clarivate.com.cn/life-sciences-healthcare/blog/pharmas-pain-from-the-inflation-reduction-act-will-be-felt-well-beyond-the-first-10-brands-facing-price-cuts/ 2026-03-12T08:23:48+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/wp-content/uploads/sites/4/2025/01/the_inflation_reduction_act_picture1.jpg https://www.clarivate.com.cn/life-sciences-healthcare/wp-content/uploads/sites/4/2025/01/the_inflation_reduction_act_picture2.jpg https://www.clarivate.com.cn/life-sciences-healthcare/wp-content/uploads/sites/4/2025/01/the_inflation_reduction_act_picture3.jpg https://www.clarivate.com.cn/life-sciences-healthcare/wp-content/uploads/sites/4/2025/01/the_inflation_reduction_act_picture4.jpg https://www.clarivate.com.cn/life-sciences-healthcare/wp-content/uploads/sites/4/2025/01/the_inflation_reduction_act_picture5.jpg https://www.clarivate.com.cn/life-sciences-healthcare/blog/drug-combinations-your-questions-answered/ 2026-03-12T08:17:31+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/wp-content/uploads/sites/4/2025/01/drug_combinations_picture1.png https://www.clarivate.com.cn/life-sciences-healthcare/blog/pharma-is-placing-bigger-bets-on-fewer-more-strategic-assets-platforms/ 2026-03-12T08:09:27+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/blog/understanding-the-epidemiology-of-sma/ 2026-03-12T08:01:55+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/blog/what-healthcare-payers-reward-adherence-versus-outcomes/ 2026-03-12T07:57:50+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/blog/payer-engagement-strategies-for-pharmas/ 2026-03-12T07:57:07+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/blog/these-six-radioligand-therapy-companies-to-watch-are-ushering-in-a-new-era-of-precision-oncology/ 2026-03-12T07:50:38+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/blog/how-clarivate-works-towards-sdg-3/ 2026-03-12T07:35:16+00:00 https://www.clarivate.com.cn/life-sciences-healthcare/blog/drug-repurposing-real-world-data-and-ai-ml-perspectives-and-opportunities/ 2026-03-12T07:05:18+00:00